2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Placebo Linezolid: new trials by email Literature Review of Placebo Linezolid trials Research Report on Placebo Linezolid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis Pretomanid, Linezolid, Bedaquiline - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 3 | Completed | Global Alliance for TB Drug Development | 181 | 2017-11-21 | 2023-06-29 |
| Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Tedizolid (BAY119-2631), Placebo Tedizolid (BAY119-2631), Linezolid - Bacterial Infections | Phase 3 | Completed | Bayer | 598 | 2014-03-04 | 2017-06-07 |
Bacterial Infections (1) · Extensively Drug-Resistant Tuberculosis (1) · Tuberculosis (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Pulmonary (1)
Bayer (1) · Global Alliance for TB Drug Development (1)
China (1) · Georgia (1) · Moldova (1) · Philippines (1) · Russia (1) · South Africa (1) · Taiwan (1) · United States (1)